You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 58 No. 10, October 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (144)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Cognitive Disorders
 •Public Health
 •Substance Abuse/ Alcoholism
 •Alert me on articles by topic

Neuropsychological Performance in Long-term Cannabis Users

Harrison G. Pope, Jr, MD; Amanda J. Gruber, MD; James I. Hudson, MD, SM; Marilyn A. Huestis, PhD; Deborah Yurgelun-Todd, PhD

Arch Gen Psychiatry. 2001;58:909-915.

Background  Although cannabis is the most widely used illicit drug in the United States, its long-term cognitive effects remain inadequately studied.

Methods  We recruited individuals aged 30 to 55 years in 3 groups: (1) 63 current heavy users who had smoked cannabis at least 5000 times in their lives and who were smoking daily at study entry; (2) 45 former heavy users who had also smoked at least 5000 times but fewer than 12 times in the last 3 months; and (3) 72 control subjects who had smoked no more than 50 times in their lives. Subjects underwent a 28-day washout from cannabis use, monitored by observed urine samples. On days 0, 1, 7, and 28, we administered a neuropsychological test battery to assess general intellectual function, abstraction ability, sustained attention, verbal fluency, and ability to learn and recall new verbal and visuospatial information. Test results were analyzed by repeated-measures regression analysis, adjusting for potentially confounding variables.

Results  At days 0, 1, and 7, current heavy users scored significantly below control subjects on recall of word lists, and this deficit was associated with users' urinary 11-nor-9-carboxy-{Delta}9-tetrahydrocannabinol concentrations at study entry. By day 28, however, there were virtually no significant differences among the groups on any of the test results, and no significant associations between cumulative lifetime cannabis use and test scores.

Conclusion  Some cognitive deficits appear detectable at least 7 days after heavy cannabis use but appear reversible and related to recent cannabis exposure rather than irreversible and related to cumulative lifetime use.


From the Biological Psychiatry Laboratory, McLean Hospital, and the Department of Psychiatry, Harvard Medical School, Belmont, Mass (Drs Pope, Gruber, Hudson, and Yurgelun-Todd); and the Intramural Research Program, National Institute on Drug Abuse, Baltimore, Md (Dr Huestis).

Corresponding author: Harrison G. Pope, Jr, MD, McLean Hospital, Harvard Medical School, 115 Mill St, Belmont, MA 02478.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A study investigating the acute dose-- response effects of 13 mg and 17 mg {Delta} 9- tetrahydrocannabinol on cognitive--motor skills, subjective and autonomic measures in regular users of marijuana
Weinstein et al.
J Psychopharmacol 2008;22:441-451.
ABSTRACT  

Multiple Sclerosis, Cannabinoids, and Cognition
Papathanasopoulos et al.
J. Neuropsychiatry Clin. Neurosi. 2008;20:36-51.
ABSTRACT | FULL TEXT  

Is there a role for marijuana in medical practice?: YES
Ware
cfp 2007;53:22-23.
FULL TEXT  

Refutation: La marijuana a-t-elle sa place dans la pratique medicale?: OUI
Ware
cfp 2007;53:24-25.
FULL TEXT  

Opposing actions of chronic {Delta}9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation
Hoffman et al.
Learn. Mem. 2007;14:63-74.
ABSTRACT | FULL TEXT  

Neuropsychological deficits in long-term frequent cannabis users
Accordino et al.
Neurology 2006;67:1902-1902.
FULL TEXT  

Psychophysiological Evidence of Altered Neural Synchronization in Cannabis Use: Relationship to Schizotypy
Skosnik et al.
Am. J. Psychiatry 2006;163:1798-1805.
ABSTRACT | FULL TEXT  

Brain Neuroimaging in Cannabis Use: A Review
Quickfall and Crockford
J. Neuropsychiatry Clin. Neurosi. 2006;18:318-332.
ABSTRACT | FULL TEXT  

Cannabis use by children and young people.
McArdle
Arch. Dis. Child. 2006;91:692-695.
ABSTRACT | FULL TEXT  

Chronic cannabis use is associated with attention-modulated reduction in prepulse inhibition of the startle reflex in healthy humans
Kedzior and Martin-Iverson
J Psychopharmacol 2006;20:471-484.
ABSTRACT  

Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction
Quednow et al.
J Psychopharmacol 2006;20:373-384.
ABSTRACT  

Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users
Reneman et al.
J Psychopharmacol 2006;20:389-399.
ABSTRACT  

Marijuana use is associated with a reorganized visual-attention network and cerebellar hypoactivation
Chang et al.
Brain 2006;129:1096-1112.
ABSTRACT | FULL TEXT  

Neuropsychological deficits in long-term frequent cannabis users
Messinis et al.
Neurology 2006;66:737-739.
ABSTRACT | FULL TEXT  

MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress
Parrott
J Psychopharmacol 2006;20:147-163.
ABSTRACT  

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview
Gouzoulis-Mayfrank and Daumann
J Psychopharmacol 2006;20:188-193.
ABSTRACT  

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective
Thomasius et al.
J Psychopharmacol 2006;20:211-225.
ABSTRACT  

Cannabis use, cognitive performance and mood in a sample of workers
Wadsworth et al.
J Psychopharmacol 2006;20:14-23.
ABSTRACT  

Executive Dysfunction in Cocaine Addiction: Evidence for Discordant Frontal, Cingulate, and Cerebellar Activity
Hester and Garavan
J. Neurosci. 2004;24:11017-11022.
ABSTRACT | FULL TEXT  

Marijuana Use and Cognitive Function in HIV-Infected People
Cristiani et al.
J. Neuropsychiatry Clin. Neurosi. 2004;16:330-335.
ABSTRACT | FULL TEXT  

Cannabis and the brain
Iversen
Brain 2003;126:1252-1270.
ABSTRACT | FULL TEXT  

Regulation of Extracellular Signal-Regulated Kinase by Cannabinoids in Hippocampus
Derkinderen et al.
J. Neurosci. 2003;23:2371-2382.
ABSTRACT | FULL TEXT  

November 12 Highlights
Neurology 2002;59:1295-1297.
FULL TEXT  

Dose-related neurocognitive effects of marijuana use
Bolla et al.
Neurology 2002;59:1337-1343.
ABSTRACT | FULL TEXT  

Does Marijuana Use Cause Long-term Cognitive Deficits?
Gunderson et al.
JAMA 2002;287:2652-2654.
FULL TEXT  

Cannabis, Cognition, and Residual Confounding
Pope
JAMA 2002;287:1172-1174.
FULL TEXT  

Long-Term Cognitive Consequences of 'Safer' Recreational Drugs
JWatch General 2001;2001:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.